Argus raised the firm’s price target on Boston Scientific (BSX) to $130 from $105 and keeps a Buy rating on the shares. The firm sees strong ...
In a post on LinkedIn, Subsense announced today that it emerged from stealth mode with $17 million in seed financing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback